1887

Abstract

CD34+ myeloid lineage progenitor cells are an important reservoir of latent human cytomegalovirus (HCMV), and differentiation to macrophages or dendritic cells (DCs) is known to cause reactivation of latent virus. Due to its species-specificity, murine models have been used to study mouse CMV (MCMV) latency and reactivation . While previous studies have shown that MCMV genomic DNA can be detected in the bone marrow (BM) of latently infected mice, the identity of these cells has not been defined. Therefore, we sought to identify and enrich for cellular sites of MCMV latency in the BM haematopoietic system, and to explore the potential for establishing an model for reactivation of latent MCMV. We studied the kinetics and cellular characteristics of acute infection and establishment of latency in the BM of mice. We found that while MCMV can infect a broad range of haematopoietic BM cells (BMCs), latent virus is only detectable in haematopoietic stem cells (HSCs), myeloid progenitor cells, monocytes and DC-enriched cell subsets. Using three separate approaches, MCMV reactivation was detected in association with differentiation into DC-enriched BMCs cultured in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 4 (IL-4) followed by lipopolysaccharide (LPS) treatment. In summary, we have defined the kinetics and cellular profile of MCMV infection followed by the natural establishment of latency in the mouse BM haematopoietic system, including the haematopoietic phenotypes of cells that are permissive to acute infection, establish and harbour detectable latent virus, and can be stimulated to reactivate following DC enrichment and differentiation, followed by treatment with LPS.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001327
2019-10-24
2019-11-22
Loading full text...

Full text loading...

References

  1. Ariza-Heredia EJ, Nesher L, Chemaly RF. Chemaly, Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett 2014;342: 1– 8 [CrossRef]
    [Google Scholar]
  2. Sing GK, Ruscetti FW. The role of human Cytomegalovirus in haematological diseases. Baillieres Clin Haematol 1995;8: 149– 163 [CrossRef]
    [Google Scholar]
  3. Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC et al. Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 1996;88: 1277– 1283
    [Google Scholar]
  4. Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 1990;87: 1386– 1390 [CrossRef]
    [Google Scholar]
  5. von Laer D, Meyer-Koenig U, Serr A, Finke J, Kanz L et al. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 1995;86: 4086– 4090
    [Google Scholar]
  6. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996;77: 3099– 3102 [CrossRef]
    [Google Scholar]
  7. Khaiboullina SF, Maciejewski JP, Crapnell K, Spallone PA, Dean Stock A et al. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 2004;126: 410– 417 [CrossRef]
    [Google Scholar]
  8. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72: 2059– 2064 [CrossRef]
    [Google Scholar]
  9. Taylor-Wiedeman J, Hayhurst GP, Sissons JGP, Sinclair JH. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol 1993;74: 265– 268 [CrossRef]
    [Google Scholar]
  10. Reeves MB, Compton T. Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 2011;85: 12750– 12758 [CrossRef]
    [Google Scholar]
  11. Reeves MB, MacAry PA, Lehner PJ, Sissons JGP, Sinclair JH et al. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005;102: 4140– 4145 [CrossRef]
    [Google Scholar]
  12. Söderberg-Nauclér C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP et al. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 2001;75: 7543– 7554 [CrossRef]
    [Google Scholar]
  13. Taylor-Wiedeman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994;68: 1597– 1604
    [Google Scholar]
  14. Huang MM, Kew VG, Jestice K, Wills MR, Reeves MB et al. Efficient human cytomegalovirus reactivation is maturation dependent in the langerhans dendritic cell lineage and can be studied using a CD14+ +experimental latency model. J Virol 2012;86: 8507– 8515 [CrossRef]
    [Google Scholar]
  15. Keil GM, Ebeling-Keil A, Koszinowski UH. Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol 1987;61: 526– 533
    [Google Scholar]
  16. Keil GM, Ebeling-Keil A, Koszinowski UH. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J Virol 1987;61: 1901– 1908
    [Google Scholar]
  17. Messerle M, Bühler B, Keil GM, Koszinowski UH. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol 1992;66: 27– 36
    [Google Scholar]
  18. Mocarski E. Cytomegaloviruses and their replicatio In David MK, Howley PM. (editors) Fields Virology Philadelphia: Lippincott Williams & Wilkins; 2001; pp 2629– 2673
    [Google Scholar]
  19. Lawson CM, O'Donoghue HL, Reed WD. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology 1992;75: 513– 519
    [Google Scholar]
  20. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol 2002;25: 123– 136 [CrossRef]
    [Google Scholar]
  21. Melnick M, Mocarski ES, Abichaker G, Huang J, Jaskoll T et al. Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol 2006;6: 42 [CrossRef]
    [Google Scholar]
  22. Juanjuan C, Yan F, Li C, Haizhi L, Ling W et al. Murine model for congenital CMV infection and hearing impairment. Virol J 2011;8: 70 [CrossRef]
    [Google Scholar]
  23. Cekinovic D, Lisnic VJ, Jonjic S. Rodent models of congenital cytomegalovirus infection. Methods Mol Biol 2014;1119: 289– 310 [CrossRef]
    [Google Scholar]
  24. Oduro JD, Redeker A, Lemmermann NAW, Ebermann L, Marandu TF et al. Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection. J Gen Virol 2016;97: 185– 195 [CrossRef]
    [Google Scholar]
  25. Duppach J, Francois S, Joedicke JJ, Dittmer U, Kraft ARM et al. Expanded regulatory T cells in chronically friend retrovirus-infected mice suppress immunity to a murine cytomegalovirus superinfection. J Virol 2014;88: 13892– 13896 [CrossRef]
    [Google Scholar]
  26. Bale JF, O'Neil ME, Giller R, Perlman S, Koszinowski U et al. Murine cytomegalovirus genomic material in marrow cells: relation to altered leukocyte counts during sublethal infection of mice. J Infect Dis 1987;155: 207– 212 [CrossRef]
    [Google Scholar]
  27. Gibbons AE, Price P, Shellam GR. Analysis of hematopoietic stem and progenitor cell populations in cytomegalovirus-infected mice. Blood 1995;86: 473– 481
    [Google Scholar]
  28. Mori T, Ando K, Tanaka K, Ikeda Y, Koga Y et al. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood 1997;89: 3565– 3573
    [Google Scholar]
  29. Pollock JL, Presti RM, Paetzold S, Virgin HW. Latent murine cytomegalovirus infection in macrophages. Virology 1997;227: 168– 179 [CrossRef]
    [Google Scholar]
  30. Koffron AJ, Hummel M, Patterson BK, Yan S, Kaufman DB et al. Cellular localization of latent murine cytomegalovirus. J Virol 1998;72: 95– 103
    [Google Scholar]
  31. van Den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ et al. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci 1999;19: 10948– 10965 [CrossRef]
    [Google Scholar]
  32. Brizić I, Lisnić B, Brune W, Hengel H, Jonjić S. Cytomegalovirus Infection: Mouse Model. Curr Protoc Immunol 2018;122: e51 [CrossRef]
    [Google Scholar]
  33. Zheng J, Umikawa M, Zhang S, Huynh H, Silvany R et al. Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation. Cell Stem Cell 2011;9: 119– 130 [CrossRef]
    [Google Scholar]
  34. Assouvie A, Daley-Bauer LP, Rousselet G. Growing murine bone marrow-derived macrophages. Methods Mol Biol 1784;2018: 29– 33
    [Google Scholar]
  35. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223: 77– 92 [CrossRef]
    [Google Scholar]
  36. Liu XF, Yan S, Abecassis M, Hummel M. Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivo. J Virol 2010;84: 3631– 3643 [CrossRef]
    [Google Scholar]
  37. Mercer JA, Spector DH. Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol 1986;57: 497– 504
    [Google Scholar]
  38. Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol 1987;41: 543– 571 [CrossRef]
    [Google Scholar]
  39. Wang LD, Wagers AJ. Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol 2011;12: 643– 655 [CrossRef]
    [Google Scholar]
  40. Francke A, Herold J, Weinert S, Strasser RH, Braun-Dullaeus RC et al. Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J Histochem Cytochem 2011;59: 813– 825 [CrossRef]
    [Google Scholar]
  41. Pergam SA, Xie H, Sandhu R, Pollack M, Smith J et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant 2012;18: 1391– 1400 [CrossRef]
    [Google Scholar]
  42. Roback JD, Su L, Newman JL, Saakadze N, Lezhava LJ et al. Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice. Transfusion 2006;46: 889– 895 [CrossRef]
    [Google Scholar]
  43. Seckert CK, Renzaho A, Reddehase MJ, Grzimek NKA. Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol 2008;197: 251– 259 [CrossRef]
    [Google Scholar]
  44. Peng R, Wang D, Wang B, Xia G, Li Y et al. Apoptosis of hemopoietic cells in irradiated mouse bone marrow. J Environ Pathol Toxicol Oncol 1999;18: 305– 308
    [Google Scholar]
  45. Turner RT, Iwaniec UT, Wong CP, Lindenmaier LB, Wagner LA et al. Acute exposure to high dose γ-radiation results in transient activation of bone lining cells. Bone 2013;57: 164– 173 [CrossRef]
    [Google Scholar]
  46. Wiesmann A, Spangrude GJ. Marrow engraftment of hematopoietic stem and progenitor cells is independent of Galphai-coupled chemokine receptors. Exp Hematol 1999;27: 946– 955 [CrossRef]
    [Google Scholar]
  47. Reeves MB, Lehner PJ, Sissons JGP, Sinclair JH. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 2005;86: 2949– 2954 [CrossRef]
    [Google Scholar]
  48. Hargett D, Shenk TE. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci USA 2010;107: 20039– 20044 [CrossRef]
    [Google Scholar]
  49. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007;178: 5245– 5252 [CrossRef]
    [Google Scholar]
  50. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J et al. Defining GM-CSF- and Macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol 2012;188: 5752– 5765 [CrossRef]
    [Google Scholar]
  51. Schrier RD, Nelson JA, Oldstone MB. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985;230: 1048– 1051 [CrossRef]
    [Google Scholar]
  52. Rice GP, Schrier RD, Oldstone MB. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci USA 1984;81: 6134– 6138 [CrossRef]
    [Google Scholar]
  53. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB et al. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 1994;68: 6243– 6253
    [Google Scholar]
  54. Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES. Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe 2014;15: 351– 362 [CrossRef]
    [Google Scholar]
  55. Farrell HE, Bruce K, Lawler C, Oliveira M, Cardin R et al. Murine cytomegalovirus spreads by dendritic cell recirculation. mBio 2017;8: e01264– 17 [CrossRef]
    [Google Scholar]
  56. Mitchell BM, Leung A, Stevens JG. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology 1996;223: 198– 207 [CrossRef]
    [Google Scholar]
  57. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 1999;93: 394– 398
    [Google Scholar]
  58. Goodrum FD, Jordan CT, High K, Shenk T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 2002;99: 16255– 16260 [CrossRef]
    [Google Scholar]
  59. O'Connor CM, Murphy EA. A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J Virol 2012;86: 9854– 9865 [CrossRef]
    [Google Scholar]
  60. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T et al. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 2004;104: 687– 695 [CrossRef]
    [Google Scholar]
  61. Rauwel B, Jang SM, Cassano M, Kapopoulou A, Barde I et al. Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. elife 2015;4: [CrossRef]
    [Google Scholar]
  62. Zhu D, Pan C, Sheng J, Liang H, Bian Z et al. Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency. Nat Microbiol 2018;3: 503– 513 [CrossRef]
    [Google Scholar]
  63. Goodrum F, Reeves M, Sinclair J, High K, Shenk T et al. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 2007;110: 937– 945 [CrossRef]
    [Google Scholar]
  64. Minton EJ, Tysoe C, Sinclair JH, Sissons JG. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 1994;68: 4017– 4021
    [Google Scholar]
  65. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998;95: 3937– 3942 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001327
Loading
/content/journal/jgv/10.1099/jgv.0.001327
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error